Everybody knows the "So Called" President is a lying POS.
"Accurate diagnosis is critical for pandemic influenza recognition, surveillance, and public health interventions. Without available and reliable laboratory testing, early response efforts are fraught with uncertainty and delays. In 2007, the Centers for Disease Control and Prevention (CDC), along with other federal agencies and laboratory partners, began implementing a strategy for improving global diagnostic preparedness for pandemic influenza. This plan included development of new diagnostic tests, guidance to clinicians, increased capacity for critical diagnostic reagents, and enhancement of surveillance for novel influenza virus strains.
In April 2009, the emergence of a transmissible, novel, swine-origin influenza virus among humans prompted public health and clinical laboratories to quickly identify means for diagnosing suspected cases and monitoring the spread of influenza illness. Over the months after the recognition of the 2009 pandemic influenza A H1N1 (pH1N1) virus, testing was performed at various points across the spectrum of clinical laboratories, ranging from high-complexity reference laboratories to point-of-care testing in clinicians' offices. The availability, speed, and accuracy of testing varied considerably and revealed a number of challenges for clinicians and public health officials in providing medical care and responding to the pandemic. In this article, we describe the important role of molecular diagnostic testing, the benefit of predeployed testing capacity in public health laboratories, and the challenges of patient treatment decisions when accurate clinical diagnostic tests are not available."
Detecting 2009 Pandemic Influenza A (H1N1) Virus Infection: Availability of Diagnostic Testing Led to Rapid Pandemic Response
CONCLUSION
Within 2 weeks after the first recognition of a pandemic influenza virus, a new, FDA-authorized, accurate, sensitive, and virus-specific diagnostic test was manufactured and distributed to laboratories in the United States and abroad. The rapid availability of virus sequence information and the quick translation of these data into diagnostic tools allowed clinicians and public health officials in the United States and worldwide to determine the magnitude of the emerging pandemic, to identify groups at highest risk of infection, and to tailor vaccine and treatment recommendations to have the greatest impact.
2009 H1N1 Flu Pandemic Timeline